Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
Crossref DOI link: https://doi.org/10.1186/2049-3002-2-S1-P14
Published Online: 2014-05-28
Published Print: 2014-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Telang, Sucheta
O’Neal, Julie
Tapolsky, Gilles
Clem, Brian
Kerr, Alan
Imbert-Ferndandez, Yoannis
Chesney, Jason
Article History
First Online: 28 May 2014